US3278393A - Selective culture medium for microorganisms and use thereof - Google Patents
Selective culture medium for microorganisms and use thereof Download PDFInfo
- Publication number
- US3278393A US3278393A US364283A US36428364A US3278393A US 3278393 A US3278393 A US 3278393A US 364283 A US364283 A US 364283A US 36428364 A US36428364 A US 36428364A US 3278393 A US3278393 A US 3278393A
- Authority
- US
- United States
- Prior art keywords
- culture medium
- staphylococcus aureus
- microorganisms
- medium
- mannitol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000001963 growth medium Substances 0.000 title claims description 38
- 244000005700 microbiome Species 0.000 title claims description 18
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 30
- 241000191967 Staphylococcus aureus Species 0.000 claims description 27
- 239000002609 medium Substances 0.000 claims description 18
- 229910052793 cadmium Inorganic materials 0.000 claims description 10
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 description 19
- 241000295644 Staphylococcaceae Species 0.000 description 16
- 210000002381 plasma Anatomy 0.000 description 13
- 241000589516 Pseudomonas Species 0.000 description 12
- 229930195725 Mannitol Natural products 0.000 description 10
- 239000000594 mannitol Substances 0.000 description 10
- 229920001817 Agar Polymers 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 7
- 150000001540 azides Chemical class 0.000 description 7
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 239000003833 bile salt Substances 0.000 description 5
- 150000001661 cadmium Chemical class 0.000 description 5
- 238000002955 isolation Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 108010065152 Coagulase Proteins 0.000 description 4
- 206010053567 Coagulopathies Diseases 0.000 description 4
- 241000191940 Staphylococcus Species 0.000 description 4
- 230000035602 clotting Effects 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000012736 aqueous medium Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- WHWDWIHXSPCOKZ-UHFFFAOYSA-N hexahydrofarnesyl acetone Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)=O WHWDWIHXSPCOKZ-UHFFFAOYSA-N 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 108010009004 proteose-peptone Proteins 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- ABIUHPWEYMSGSR-UHFFFAOYSA-N bromocresol purple Chemical compound BrC1=C(O)C(C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C=C(Br)C(O)=C(C)C=2)=C1 ABIUHPWEYMSGSR-UHFFFAOYSA-N 0.000 description 2
- NUHCTOLBWMJMLX-UHFFFAOYSA-N bromothymol blue Chemical compound BrC1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C(=C(Br)C(O)=C(C(C)C)C=2)C)=C1C NUHCTOLBWMJMLX-UHFFFAOYSA-N 0.000 description 2
- YKYOUMDCQGMQQO-UHFFFAOYSA-L cadmium dichloride Chemical compound Cl[Cd]Cl YKYOUMDCQGMQQO-UHFFFAOYSA-L 0.000 description 2
- XIEPJMXMMWZAAV-UHFFFAOYSA-N cadmium nitrate Inorganic materials [Cd+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O XIEPJMXMMWZAAV-UHFFFAOYSA-N 0.000 description 2
- NRGIRRZWCDKDMV-UHFFFAOYSA-H cadmium(2+);diphosphate Chemical compound [Cd+2].[Cd+2].[Cd+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O NRGIRRZWCDKDMV-UHFFFAOYSA-H 0.000 description 2
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 2
- 229960003964 deoxycholic acid Drugs 0.000 description 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000007793 ph indicator Substances 0.000 description 2
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000004224 potassium gluconate Substances 0.000 description 1
- 229960003189 potassium gluconate Drugs 0.000 description 1
- 235000013926 potassium gluconate Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 229940093916 potassium phosphate Drugs 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- -1 sodium azide Chemical class 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/80—Elimination or reduction of contamination by undersired ferments, e.g. aseptic cultivation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/874—Pseudomonas
- Y10S435/875—Pseudomonas aeruginosa
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/882—Staphylococcus
- Y10S435/883—Staphylococcus aureus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/882—Staphylococcus
- Y10S435/884—Staphylococcus epidermidis
Definitions
- this invention relates to a culture medium for distinguishing Staphylococcus aureus and Pseudomonas aeruginosa from other pathogenic microorganisms and others that may be morphologically similar and from nonpatho-genic staphylococci organisms.
- the staphylococci are by far the commonest cause of skin infections such as boils, abcesses, carbuncles and similar suppurative processes in man. They are primarily significant as pathogens. They can be grown on culture media, such as agar or meat extract media, and the individual colonies are circular with entire edges.
- the pathogenic forms that is, those isolated from suppurative processes, usually are Staphylococcus aureus.
- Staphylococci ferment mannitol with the formation of acid being detected by a decrease in pH of the media, as evidenced by color change of a pH indicator such as brom thymol blue or brom cresol purple.
- Pathogenic staphylococci that is, the Staphylococcus aurcus, cause clotting of decalcified blood plasma due to the production of staphylocoagulase, an active clotting agent.
- staphylococcal virulence for man and staphylocoagulase production.
- Coagulase-positive bacteria are usually virulent.
- Plasma clotting i.e., staphylocoagulase activity
- Plasma clotting can be demonstrated by mixing a bacterial culture with decalcified plasma, human or rabbit, incubating the plasma and observing clotting.
- the simple slide method is often used for qualitative purposes; the bacteria are suspended in a drop of plasma and observed on a slide for clumping.
- Staphylococci constitute the normal flora of the human skin, mouth and upper respiratory tract and enter the body through the intact skin or breaks therein. They include the relatively avirulent Staphylococcus epidermia'is, as well as the virulent Staphylococcus aureus, especially in the upper respiratory tract. The latter are the etiologic basis for a variety of skin lesions, as well as diseases of the respiratory tract. Staphylococcal infections have increased in prevalence and fatality in recent years and are the predominant bacterial infections in this country.
- Pseudomonas aeruginosa is a common cause of hospital infections, particularly in burns, and it is desirable to have a culture medium which will aid in distinguishing this organism from other pathogens.
- a culture medium containing a cadmium salt such as cadmium nitrate, phosphate or chloride is effective as a selective medium for the culture of pathogenic Staphylococcus aureus.
- This culture medium aids in the identification of pathogenic Staphylococcus aureus from other staphylococci and other microorganisms.
- the remaining components in the culture medium are conventional materials such as agar, proteosepeptone fractions, potassium phosphate, yeast extract, peptones, mannitol and pH indicators which indicate acid production.
- Staphylococcus from a wound is usually not a difiicult matter. Inoculation of a blood agar medium with the organism from a purulent specimen followed by 24 hours incubation at 37 C. gives a good growth of colonies. With Staphylococcus aureus 24 hours incubation gives good growth of creamy colonies that are surrounded by the clear zones of ,8 hemolysis. When the medium is rendered selective by the inclusion of the cadmium salt, it is possible to isolate Staphylococcus aureus from specimens heavily contaminated with other bacteria.
- Pseudomonas strains can grow in the cadmiuma-gar medium, it may be necessary to distinguish them from Staphylococcus aureus. This can be done by the mannitol fermentation and plasma coagulation tests.
- the mannitol fermentation test can be conducted in the same medium in which the bacteria are grown. A drop in pH of the medium indicates that the mannitol has been converted to acid by fermentation.
- Pseudomonas bacilli and nonpathogenic staphylococci such as Staphylococcus epidermidis
- the plasma coagulation test confirms this fact, as Pseudomonas bacilli and nonpathogenic staphylococci do not coagulate decalcified blood plasma.
- Staphylococcus aureus is by addition of a soluble azide, such as sodium azide, to the culture medium.
- a soluble azide such as sodium azide
- the azide inhibits pseudomonas strains while allowing the staphylococci to develop.
- Pseudomonas aeruginosa can be distinguished from Staphylococcus aureus by addition of a bile salt, such as sodium desoxycholate or other soluble salt of desoxycholic acid, to the culture medium.
- a bile salt such as sodium desoxycholate or other soluble salt of desoxycholic acid
- the culture medium can be a standard agar medium containing 0.002 to 0.4 gram of CdCl -2' A2H O per liter or equivalent amount of cadmium as cadmiun nitrate or cadmium phosphate.
- the culture medium can also contain D-mannitol, which has been used in other staphylooccus selective media, in concentration in the range of 20 grams per liter to aid in distinguishing Staphylococcus aureus from pseudomonas and from other staphylococci organisms.
- a suitable c-admium-mannitol-agar culture medium corresponds to the following formulation:
- An indicator such as 0.04% brom thymol blue or 0.04% brom cresol purple may be added to indicate acid production by a color change.
- the media of this specification can be used for the detection and enumeration of staphylococci.
- Most microorganisms with the exception of Pseudomonas are inhibited by the cadmium salt in the media.
- the exception to this are fecal samples where Proteus may grow. Plates can be heavily inoculated because of the inhibitory action of the cadmium salt. The inoculated plates are then incubated for 24-36 hours at approximately 37 C. Most of the colonies that grow on the media will usually ferment the mannitol.
- Organisms which grow and do not ferment the mannitol or coagulate plasma are nonpathogenic staphylococci or Pseudomonas. Those that grow, ferment mannitol and coagulate plasma are Staphylococcus aureus pathogens.
- Selective culture media for the detection and enumeration of Staphylococcus aureus and for distinguishing it from Pseudomonas aeruginosa can be produced by the addition of 0.0004 to 0.4 gram per liter of sodium azide or other soluble azide to the media described hereinabove.
- the azide will prevent growth of Pseudomonas strains, so that the mannitol fermentation or plasma coagulation tests need not be used to distinguish Staphylococcus aureus from these strains.
- a typical selective culture medium for Staphylococcus aureus is the following, which will give a pure culture in purulent wounds:
- Selective culture media for the detection of Pseudomonas aeruginosa and for distinguishing this strain from staphylococci correspond to the foregoing formula with 0.005 to 10 grams per liter of a bile salt such as potassium desoxycholate (or other soluble salt of desoxycholic acid) in lieu of the azide.
- a typical formula is the following:
- Media for isolation of Pseudomonas organisms can be incubated at temperatures from C. to 42 C. for periods of 24 to 48 hours.
- Media for isolation of staphylococci can be incubated at C. to 37.5 C. for periods of 24 to 48 hours.
- Such media are aqueous media, whether in form of broths or agar gels, and are so described herein.
- a selective culture medium for the identification of microorganisms which comprises an aqueous medium containing a cadmium salt selected from the group consisting of cadmium nitrate, cadmium phosphate and cadmium chloride, the concentration of cadmium in said aqueous medium being equivalent to 0.002 to 0.4 gram of CdCl -2' /2H O per liter, and D-mannitol, the concentration of the D-mannitol being in the range from 5 to 20 grams per liter.
- a cadmium salt selected from the group consisting of cadmium nitrate, cadmium phosphate and cadmium chloride
- a selective culture medium for identification of microorganisms as defined by claim 1 containing a soluble azide in concentration of 0.0004 to 0.4 gram per liter.
- a selective culture medium for identification of microorganisms as defined by claim 1 containing a bile salt in concentration of 0.005 to 10 grams per liter.
- a selective culture medium for identification of microorganisms as defined by claim 3 containing a soluble desoxycholate in concentration of 0.005 to 10 grams per liter.
- a method of identifying Staphylococcus aureus in a specimen of microorganisms which comprises inoculating a culture medium with said specimen, the culture medium containing cadmium in an amount equivalent to 2 to 400 parts of CdCl -2 /2H O per million and containing 5 to 25 grams D-mannitol per liter of culture medium, incubating the inoculated medium at approximately 37 C., measuring the change in pH of the medium, and removing from the culture medium a specimen of the colony grown therein and admixing said specimen with decalcified blood plasma, thereby identifying Staphylococcus aureus by its characteristics of growing in a medium containing cadmium, fermenting D-mannitol to form acid, and coagulating decalcified blood plasma.
- a method of isolating Staphylococcus aureus in a specimen of microorganisms which comprises inoculating a culture medium with said specimen, the culture medium containing cadmium in an amount equivalent to 0.002 to 0.4 gram of CdCl -2V2H O per liter and containing a soluble azide in concentration of 0.0004 to 0.4 gram per liter, and incubating the medium at a temperature in the range of about 35 to 375 C., whereby the Staphylococcus aureus is permitted to grow while other organisms are inhibited.
- a method of isolating Pseudomonas aeruginosa in a specimen of microorganisms which comprises inoculating a culture medium with said specimen, the culture medium containing cadmium in an amount equivalent to 0.002 to 0.4 gram of CdCl -2 /zH O per liter and containing a bile salt in concentration of 0.005 to 10 grams per liter, and incubating the medium at a temperature in the range of about 20 to 42 C., whereby the Pseudomonas aeruginosa is permitted to grow while other organisms are inhibited.
- a method of identifying Staphylococcus aureus in a specimen of microorganisms which comprises inoculating a culture medium with said specimen, the culture medium containing cadmium in an amount equivalent to 2 to 400 parts of CdCl '2 /2H O per million and containing 5 to 25 grams D-mannitol per liter of culture medium, incubating the inoculated medium at approximately 37 C., measuring the change in PH of the medium, thereby identifying Staphylococcus aureus by its characteristics of growing in a medium containing cadmium and fermenting D-mannitol to form acid.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
United States Patent 3,278,393 Patented Oct. 11, 1966 3,278,393 SELECTIVE CULTURE MEDIUM FOR MICRO- ORGANISMS AND USE THEREOF Arthur N. Bahu, Evanston, and Irving L. Shklair, Wankegan, Ill., assignors to Northwestern University, Evanston, 111., a corporation of Illinois No Drawing. Filed May 1, 1964, Ser. No. 364,283 8 Claims. (Cl. 195-100) This invention relates to a selective culture medium for microorganisms. More particularly, this invention relates to a culture medium for distinguishing Staphylococcus aureus and Pseudomonas aeruginosa from other pathogenic microorganisms and others that may be morphologically similar and from nonpatho-genic staphylococci organisms.
The staphylococci are by far the commonest cause of skin infections such as boils, abcesses, carbuncles and similar suppurative processes in man. They are primarily significant as pathogens. They can be grown on culture media, such as agar or meat extract media, and the individual colonies are circular with entire edges. The pathogenic forms, that is, those isolated from suppurative processes, usually are Staphylococcus aureus.
Staphylococci ferment mannitol with the formation of acid, the latter being detected by a decrease in pH of the media, as evidenced by color change of a pH indicator such as brom thymol blue or brom cresol purple.
Pathogenic staphylococci, that is, the Staphylococcus aurcus, cause clotting of decalcified blood plasma due to the production of staphylocoagulase, an active clotting agent. There is a high correlation between staphylococcal virulence for man and staphylocoagulase production. Coagulase-positive bacteria are usually virulent.
Plasma clotting (i.e., staphylocoagulase activity) can be demonstrated by mixing a bacterial culture with decalcified plasma, human or rabbit, incubating the plasma and observing clotting. The simple slide method is often used for qualitative purposes; the bacteria are suspended in a drop of plasma and observed on a slide for clumping.
Staphylococci constitute the normal flora of the human skin, mouth and upper respiratory tract and enter the body through the intact skin or breaks therein. They include the relatively avirulent Staphylococcus epidermia'is, as well as the virulent Staphylococcus aureus, especially in the upper respiratory tract. The latter are the etiologic basis for a variety of skin lesions, as well as diseases of the respiratory tract. Staphylococcal infections have increased in prevalence and fatality in recent years and are the predominant bacterial infections in this country.
In the treatment of wounds and similar skin lesions it is often desirable, and sometimes necessary, to identify the microorganisms in the wound for proper selection of antibiotic treatment. In the customary practice, a culture is made of the wound or lesion in an agar medium and the microorganisms developed therein. Staphylococcus aurcus is a common pathogenic microorganism in skin wounds and it is desirable to be able to identify these organisms promptly and accurately so that appropriate treatment can be instituted without delay. For this reason it is desirable to have a culture medium which contains an inhibitor which inhibits the growth of most microorganisms except Staphylococcus aureus and thus allows rapid and accurate identification of Staphylococcus aureus if present in the wound or lesion.
Pseudomonas aeruginosa is a common cause of hospital infections, particularly in burns, and it is desirable to have a culture medium which will aid in distinguishing this organism from other pathogens.
It is an object of this invention to provide a selective culture medium for microorganisms which inhibits the growth of nonpathogenic organisms, provides for the isolation of pathogenic staphylococci and distinguishes pathogenic Staphylococcus aureus from other staphylococcal organisms. It is another object to provide a selective culture medium which provides for the isolation and identification of Pseudomonas aerugz'nosa. These and other objects will be apparent from and are achieved in accordance with the following disclosure.
We have discovered that a culture medium containing a cadmium salt such as cadmium nitrate, phosphate or chloride is effective as a selective medium for the culture of pathogenic Staphylococcus aureus. This culture medium aids in the identification of pathogenic Staphylococcus aureus from other staphylococci and other microorganisms. The remaining components in the culture medium are conventional materials such as agar, proteosepeptone fractions, potassium phosphate, yeast extract, peptones, mannitol and pH indicators which indicate acid production.
The isolation of Staphylococcus from a wound is usually not a difiicult matter. Inoculation of a blood agar medium with the organism from a purulent specimen followed by 24 hours incubation at 37 C. gives a good growth of colonies. With Staphylococcus aureus 24 hours incubation gives good growth of creamy colonies that are surrounded by the clear zones of ,8 hemolysis. When the medium is rendered selective by the inclusion of the cadmium salt, it is possible to isolate Staphylococcus aureus from specimens heavily contaminated with other bacteria.
As some Pseudomonas strains can grow in the cadmiuma-gar medium, it may be necessary to distinguish them from Staphylococcus aureus. This can be done by the mannitol fermentation and plasma coagulation tests. The mannitol fermentation test can be conducted in the same medium in which the bacteria are grown. A drop in pH of the medium indicates that the mannitol has been converted to acid by fermentation. As Pseudomonas bacilli and nonpathogenic staphylococci (such as Staphylococcus epidermidis) do not ferment mannitol, they are readily distinguished from Staphylococcus aureus. The plasma coagulation test confirms this fact, as Pseudomonas bacilli and nonpathogenic staphylococci do not coagulate decalcified blood plasma.
Another and prefered way of distinguishing Staphylococcus aureus from Pseudomonas strains, such as Pseudomortas aeruginosa, is by addition of a soluble azide, such as sodium azide, to the culture medium. The azide inhibits pseudomonas strains while allowing the staphylococci to develop.
Pseudomonas aeruginosa can be distinguished from Staphylococcus aureus by addition of a bile salt, such as sodium desoxycholate or other soluble salt of desoxycholic acid, to the culture medium. Bile salts inhibit the staphylococci without significantly affecting the growth of Pseudomonas strains.
The culture medium can be a standard agar medium containing 0.002 to 0.4 gram of CdCl -2' A2H O per liter or equivalent amount of cadmium as cadmiun nitrate or cadmium phosphate. The culture medium can also contain D-mannitol, which has been used in other staphylooccus selective media, in concentration in the range of 20 grams per liter to aid in distinguishing Staphylococcus aureus from pseudomonas and from other staphylococci organisms. A suitable c-admium-mannitol-agar culture medium corresponds to the following formulation:
Formula in grams per liter of distilled water Proteose-peptone No. 3 (Difco) Phytone (BBL) 10 K HPO 2.5 Yeast extract 2.5
D-mannitol 10 CdCl -2 /2H O 0.020 to 0.25 Agar An indicator such as 0.04% brom thymol blue or 0.04% brom cresol purple may be added to indicate acid production by a color change.
The media of this specification can be used for the detection and enumeration of staphylococci. Most microorganisms with the exception of Pseudomonas are inhibited by the cadmium salt in the media. The exception to this are fecal samples where Proteus may grow. Plates can be heavily inoculated because of the inhibitory action of the cadmium salt. The inoculated plates are then incubated for 24-36 hours at approximately 37 C. Most of the colonies that grow on the media will usually ferment the mannitol. Organisms which grow and do not ferment the mannitol or coagulate plasma are nonpathogenic staphylococci or Pseudomonas. Those that grow, ferment mannitol and coagulate plasma are Staphylococcus aureus pathogens.
Selective culture media for the detection and enumeration of Staphylococcus aureus and for distinguishing it from Pseudomonas aeruginosa can be produced by the addition of 0.0004 to 0.4 gram per liter of sodium azide or other soluble azide to the media described hereinabove. The azide will prevent growth of Pseudomonas strains, so that the mannitol fermentation or plasma coagulation tests need not be used to distinguish Staphylococcus aureus from these strains. A typical selective culture medium for Staphylococcus aureus is the following, which will give a pure culture in purulent wounds:
Formula in grams per liter of distilled water Proteose-peptone No. 3 (Difco) 10 Phytone (BBL) 10 K HPO 2.5 Yeast extract 2.5 D-mannitol 10 CdCl -2' /2H O 0.02 to 0.25 Agar 15 Sodium azide 0.1-0.2
Selective culture media for the detection of Pseudomonas aeruginosa and for distinguishing this strain from staphylococci correspond to the foregoing formula with 0.005 to 10 grams per liter of a bile salt such as potassium desoxycholate (or other soluble salt of desoxycholic acid) in lieu of the azide. A typical formula is the following:
Formula in grams per liter of distilled water Peptone 15 Phytone (BBL) 5 Sodium citrate 15 Potassium gluconate 5 5 Glycerol 10 CdCl -2 /2H O 0.3 Sodium desoxycholate 0.5
Media for isolation of Pseudomonas organisms can be incubated at temperatures from C. to 42 C. for periods of 24 to 48 hours. Media for isolation of staphylococci can be incubated at C. to 37.5 C. for periods of 24 to 48 hours. Such media are aqueous media, whether in form of broths or agar gels, and are so described herein.
We claim:
1. A selective culture medium for the identification of microorganisms which comprises an aqueous medium containing a cadmium salt selected from the group consisting of cadmium nitrate, cadmium phosphate and cadmium chloride, the concentration of cadmium in said aqueous medium being equivalent to 0.002 to 0.4 gram of CdCl -2' /2H O per liter, and D-mannitol, the concentration of the D-mannitol being in the range from 5 to 20 grams per liter.
2. A selective culture medium for identification of microorganisms as defined by claim 1 containing a soluble azide in concentration of 0.0004 to 0.4 gram per liter.
3. A selective culture medium for identification of microorganisms as defined by claim 1 containing a bile salt in concentration of 0.005 to 10 grams per liter.
4. A selective culture medium for identification of microorganisms as defined by claim 3 containing a soluble desoxycholate in concentration of 0.005 to 10 grams per liter.
5. A method of identifying Staphylococcus aureus in a specimen of microorganisms which comprises inoculating a culture medium with said specimen, the culture medium containing cadmium in an amount equivalent to 2 to 400 parts of CdCl -2 /2H O per million and containing 5 to 25 grams D-mannitol per liter of culture medium, incubating the inoculated medium at approximately 37 C., measuring the change in pH of the medium, and removing from the culture medium a specimen of the colony grown therein and admixing said specimen with decalcified blood plasma, thereby identifying Staphylococcus aureus by its characteristics of growing in a medium containing cadmium, fermenting D-mannitol to form acid, and coagulating decalcified blood plasma.
6. A method of isolating Staphylococcus aureus in a specimen of microorganisms which comprises inoculating a culture medium with said specimen, the culture medium containing cadmium in an amount equivalent to 0.002 to 0.4 gram of CdCl -2V2H O per liter and containing a soluble azide in concentration of 0.0004 to 0.4 gram per liter, and incubating the medium at a temperature in the range of about 35 to 375 C., whereby the Staphylococcus aureus is permitted to grow while other organisms are inhibited.
7. A method of isolating Pseudomonas aeruginosa in a specimen of microorganisms which comprises inoculating a culture medium with said specimen, the culture medium containing cadmium in an amount equivalent to 0.002 to 0.4 gram of CdCl -2 /zH O per liter and containing a bile salt in concentration of 0.005 to 10 grams per liter, and incubating the medium at a temperature in the range of about 20 to 42 C., whereby the Pseudomonas aeruginosa is permitted to grow while other organisms are inhibited.
8. A method of identifying Staphylococcus aureus in a specimen of microorganisms which comprises inoculating a culture medium with said specimen, the culture medium containing cadmium in an amount equivalent to 2 to 400 parts of CdCl '2 /2H O per million and containing 5 to 25 grams D-mannitol per liter of culture medium, incubating the inoculated medium at approximately 37 C., measuring the change in PH of the medium, thereby identifying Staphylococcus aureus by its characteristics of growing in a medium containing cadmium and fermenting D-mannitol to form acid.
References Cited by the Examiner Wallerstein Laboratories Communications, vol. XIV, No. 47, pages 343 and 344 (1951).
A. LOUIS MONACELL, Primary Examiner.
ALV N E. TANENHOLTZ, Examiner.
Claims (1)
- 8. A METHOD OF INDENTIFYING STAPHYLOCOCCUS AUREUS IN A SPECIMEN OF MICROORGANISMS WHICH COMPRISES INOCULATING A CULTURE MEDIUM WITH SAID SPECIMEN, THE CULTURE MEDIUM CONTAINING CADMIUM IN AN AMOUNT EQUIVALENT TO 2 TO 400 PARTS OF CDCL2.C1/2H2O PER MILLION AND CONTAINING 2 TO 25 GRAMS D-MANNITOL PER LITER OF CULTURE MEDIUM INCUBATING THE INOCULATED MEDIUM AT APPROXIMATELY 37*C., MEASURING THE CHANGE IN PH OF THE MEDIUM, THEREBY IDENTIFYING STAPHYLOCOCCUS AUREUS BY ITS CHARACTERISTICS OF GROWING IN A MEDIUM CONTAINING CADMIUM AND FERMENTING D-MANNITOL TO FORM ACID.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US364283A US3278393A (en) | 1964-05-01 | 1964-05-01 | Selective culture medium for microorganisms and use thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US364283A US3278393A (en) | 1964-05-01 | 1964-05-01 | Selective culture medium for microorganisms and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3278393A true US3278393A (en) | 1966-10-11 |
Family
ID=23433822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US364283A Expired - Lifetime US3278393A (en) | 1964-05-01 | 1964-05-01 | Selective culture medium for microorganisms and use thereof |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3278393A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3399115A (en) * | 1966-02-14 | 1968-08-27 | Walter M. Sellers Jr. | Qualitative bacteria culture medium identification |
| US4375510A (en) * | 1981-03-05 | 1983-03-01 | Forsyth Dental Infirmary For Children | Selective medium composition and method for the detection of Actinomyces viscosus and Actinomyces naeslundii |
| US4666849A (en) * | 1983-10-04 | 1987-05-19 | The United States Of America As Represented By The Secretary Of Agriculture | Lactic acid bacteria which do not decarboxylate malic acid and fermentation therewith |
| US5328833A (en) * | 1991-04-04 | 1994-07-12 | Ayres William W | Device and procedure for identifying pathogenic microorganisms |
| US5817510A (en) * | 1995-02-24 | 1998-10-06 | Xechem International, Inc. | Device and method for evaluating microorganisms |
| JP2957312B2 (en) | 1991-05-21 | 1999-10-04 | 日立電子エンジニアリング株式会社 | Method for measuring viable count of Staphylococcus aureus |
-
1964
- 1964-05-01 US US364283A patent/US3278393A/en not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| None * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3399115A (en) * | 1966-02-14 | 1968-08-27 | Walter M. Sellers Jr. | Qualitative bacteria culture medium identification |
| US4375510A (en) * | 1981-03-05 | 1983-03-01 | Forsyth Dental Infirmary For Children | Selective medium composition and method for the detection of Actinomyces viscosus and Actinomyces naeslundii |
| US4666849A (en) * | 1983-10-04 | 1987-05-19 | The United States Of America As Represented By The Secretary Of Agriculture | Lactic acid bacteria which do not decarboxylate malic acid and fermentation therewith |
| US5328833A (en) * | 1991-04-04 | 1994-07-12 | Ayres William W | Device and procedure for identifying pathogenic microorganisms |
| JP2957312B2 (en) | 1991-05-21 | 1999-10-04 | 日立電子エンジニアリング株式会社 | Method for measuring viable count of Staphylococcus aureus |
| US5817510A (en) * | 1995-02-24 | 1998-10-06 | Xechem International, Inc. | Device and method for evaluating microorganisms |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| De Louvois et al. | Bacteriology of abscesses of the central nervous system: a multicentre prospective study. | |
| Fleming | On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae | |
| Fleming | On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae | |
| Ruoff | Nutritionally variant streptococci | |
| Baker | Comparison of various methods for differentiation of staphylococci and micrococci | |
| Garrod | Sensitivity of four species of Bacteroides to antibiotics | |
| Duerden et al. | The characterization of clinically important gram negative anaerobic bacilli by conventional bacteriological tests | |
| Finegold et al. | New selective and differential medium for coagulase-positive staphylococci allowing rapid growth and strain differentiation | |
| Jay | Production of lysozyme by staphylococci and its correlation with three other extracellular substances | |
| US3278393A (en) | Selective culture medium for microorganisms and use thereof | |
| Thomas et al. | The classification of anaerobic cocci and their isolation in normal human beings and pathological processes | |
| Fleming | On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae | |
| Perry et al. | Anaerobic corneal ulcers | |
| Tronca et al. | Demonstration of Neisseria gonorrhoeae with fluorescent antibody in patients with disseminated gonococcal infection | |
| Smith et al. | Dermatophyte lesions in the hedgehog as a reservoir of penicillin-resistant staphylococci | |
| Abramson | Athlete's foot caused by Pseudomonas aeruginosa | |
| Grossgebauer et al. | Lysozyme production as an aid for identification of potentially pathogenic strains of staphylococci | |
| Sampson et al. | Incidence of Staphylococcus aureus wound infection amongst patients attending University of Port Harcourt Teaching Hospital, Rivers State, Nigeria | |
| Nobechi | Contributions to the knowledge of Vibrio cholerae I. Fermentation of carbohydrates and polyatomic alcohols by Vibrio cholerae | |
| Williams | Mercury resistance and tetracycline resistance in Staphylococcus aureus | |
| US5328833A (en) | Device and procedure for identifying pathogenic microorganisms | |
| Pickett et al. | Recognition of Staphylococcus saprophyticus in urine cultures by screening colonies for production of phosphatase | |
| CA1205029A (en) | Selective agent for group a streptococci | |
| US4229530A (en) | Methods and media for rapid detection of pathogenic neisseria | |
| Eisaa | Isolation and Identification of Staphylococcus Aureus from Al-Kut Hospital in Kut City |